Amyloid Polymorphism: Structural Basis and Neurobiological Relevance

Neuron

Volumn 86, Issue 3, 2015, Pages 632-645

  Tycko, Robert ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PROTEIN; PEPTIDE DERIVATIVE; PROTEIN DERIVATIVE;

BIOLOGICAL MODEL; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; IN VITRO STUDY; MOLECULAR BIOLOGY; MOLECULAR PATHOLOGY; NEUROANATOMY; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS; TRANSGENIC ANIMAL; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETIC POLYMORPHISM; GENETICS; METABOLISM;

AMYLOID; ANIMALS; HUMANS; MODELS, MOLECULAR; NEUROBIOLOGY; POLYMORPHISM, GENETIC;

EID: 84928952443     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.03.017     Document Type: Review

References (151)

1. Ahmed M., Davis J., Aucoin D., Sato T., Ahuja S., Aimoto S., Elliott J.I., Van Nostrand W.E., Smith S.O. Structural conversion of neurotoxic amyloid-β(1-42) oligomers to fibrils. Nat. Struct. Mol. Biol. 2010, 17:561-567.
2. Aizenstein H.J., Nebes R.D., Saxton J.A., Price J.C., Mathis C.A., Tsopelas N.D., Ziolko S.K., James J.A., Snitz B.E., Houck P.R., et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch. Neurol. 2008, 65:1509-1517.
3. Andronesi O.C., von Bergen M., Biernat J., Seidel K., Griesinger C., Mandelkow E., Baldus M. Characterization of Alzheimer's-like paired helical filaments from the core domain of tau protein using solid-state NMR spectroscopy. J.Am. Chem. Soc. 2008, 130:5922-5928.
4. Antzutkin O.N., Balbach J.J., Leapman R.D., Rizzo N.W., Reed J., Tycko R. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils. Proc. Natl. Acad. Sci. USA 2000, 97:13045-13050.
5. Antzutkin O.N., Leapman R.D., Balbach J.J., Tycko R. Supramolecular structural constraints on Alzheimer's β-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry 2002, 41:15436-15450.
6. Aoyagi H., Hasegawa M., Tamaoka A. Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau. J.Biol. Chem. 2007, 282:20309-20318.
7. Ashe K.H., Aguzzi A. Prions, prionoids and pathogenic proteins in Alzheimer disease. Prion 2013, 7:55-59.
8. Balbach J.J., Petkova A.T., Oyler N.A., Antzutkin O.N., Gordon D.J., Meredith S.C., Tycko R. Supramolecular structure in full-length Alzheimer's β-amyloid fibrils: evidence for a parallel β-sheet organization from solid-state nuclear magnetic resonance. Biophys. J. 2002, 83:1205-1216.
9. Bedrood S., Li Y., Isas J.M., Hegde B.G., Baxa U., Haworth I.S., Langen R. Fibril structure of human islet amyloid polypeptide. J.Biol. Chem. 2012, 287:5235-5241.
10. Benzinger T.L.S., Gregory D.M., Burkoth T.S., Miller-Auer H., Lynn D.G., Botto R.E., Meredith S.C. Propagating structure of Alzheimer's β-amyloid(10-35) is parallel β-sheet with residues in exact register. Proc. Natl. Acad. Sci. USA 1998, 95:13407-13412.
11. Bertini I., Gonnelli L., Luchinat C., Mao J., Nesi A. A new structural model of Aβ40 fibrils. J.Am. Chem. Soc. 2011, 133:16013-16022.
12. Bousset L., Pieri L., Ruiz-Arlandis G., Gath J., Jensen P.H., Habenstein B., Madiona K., Olieric V., Böckmann A., Meier B.H., Melki R. Structural and functional characterization of two α-synuclein strains. Nat. Commun. 2013, 4:2575.
13. Caughey B., Raymond G.J., Bessen R.A. Strain-dependent differences in β-sheet conformations of abnormal prion protein. J.Biol. Chem. 1998, 273:32230-32235.
14. Chen S., Ferrone F.A., Wetzel R. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. USA 2002, 99:11884-11889.
15. Chen M., Margittai M., Chen J., Langen R. Investigation of α-synuclein fibril structure by site-directed spin labeling. J.Biol. Chem. 2007, 282:24970-24979.
16. Chételat G., Villemagne V.L., Villain N., Jones G., Ellis K.A., Ames D., Martins R.N., Masters C.L., Rowe C.C., Grp A.R. Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition. Neurology 2012, 78:477-484. AIBL Research Group.
17. Chimon S., Ishii Y. Capturing intermediate structures of Alzheimer's β-amyloid, Abeta(1-40), by solid-state NMR spectroscopy. J.Am. Chem. Soc. 2005, 127:13472-13473.
18. Chimon S., Shaibat M.A., Jones C.R., Calero D.C., Aizezi B., Ishii Y. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid. Nat. Struct. Mol. Biol. 2007, 14:1157-1164.
19. Clavaguera F., Akatsu H., Fraser G., Crowther R.A., Frank S., Hench J., Probst A., Winkler D.T., Reichwald J., Staufenbiel M., et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc. Natl. Acad. Sci. USA 2013, 110:9535-9540.
20. Cobb N.J., Sönnichsen F.D., McHaourab H., Surewicz W.K. Molecular architecture of human prion protein amyloid: a parallel, in-register β-structure. Proc. Natl. Acad. Sci. USA 2007, 104:18946-18951.
21. Cohen S.I.A., Linse S., Luheshi L.M., Hellstrand E., White D.A., Rajah L., Otzen D.E., Vendruscolo M., Dobson C.M., Knowles T.P.J. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl. Acad. Sci. USA 2013, 110:9758-9763.
22. Collinge J., Clarke A.R. A general model of prion strains and their pathogenicity. Science 2007, 318:930-936.
23. Comellas G., Lemkau L.R., Nieuwkoop A.J., Kloepper K.D., Ladror D.T., Ebisu R., Woods W.S., Lipton A.S., George J.M., Rienstra C.M. Structured regions of α-synuclein fibrils include the early-onset Parkinson's disease mutation sites. J.Mol. Biol. 2011, 411:881-895.
24. Cunningham C. Microglia and neurodegeneration: the role of systemic inflammation. Glia 2013, 61:71-90.
25. Daebel V., Chinnathambi S., Biernat J., Schwalbe M., Habenstein B., Loquet A., Akoury E., Tepper K., Müller H., Baldus M., et al. β-Sheet core of tau paired helical filaments revealed by solid-state NMR. J.Am. Chem. Soc. 2012, 134:13982-13989.
26. De Paëpe G. Dipolar recoupling in magic angle spinning solid-state nuclear magnetic resonance. Annu. Rev. Phys. Chem. 2012, 63:661-684.
27. Der-Sarkissian A., Jao C.C., Chen J., Langen R. Structural organization of α-synuclein fibrils studied by site-directed spin labeling. J.Biol. Chem. 2003, 278:37530-37535.
28. Dickson D.W., Ahmed Z., Algom A.A., Tsuboi Y., Josephs K.A. Neuropathology of variants of progressive supranuclear palsy. Curr. Opin. Neurol. 2010, 23:394-400.
29. Eanes E.D., Glenner G.G. X-ray diffraction studies on amyloid filaments. J.Histochem. Cytochem. 1968, 16:673-677.
30. Eisele Y.S., Obermüller U., Heilbronner G., Baumann F., Kaeser S.A., Wolburg H., Walker L.C., Staufenbiel M., Heikenwalder M., Jucker M. Peripherally applied Abeta-containing inoculates induce cerebral β-amyloidosis. Science 2010, 330:980-982.
31. Eskici G., Axelsen P.H. Copper and oxidative stress in the pathogenesis of Alzheimer's disease. Biochemistry 2012, 51:6289-6311.
32. Estrada L.D., Soto C. Disrupting β-amyloid aggregation for Alzheimer disease treatment. Curr. Top. Med. Chem. 2007, 7:115-126.
33. Fleisher A.S., Chen K., Liu X., Roontiva A., Thiyyagura P., Ayutyanont N., Joshi A.D., Clark C.M., Mintun M.A., Pontecorvo M.J., et al. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch. Neurol. 2011, 68:1404-1411.
34. Franks W.T., Wylie B.J., Schmidt H.L.F., Nieuwkoop A.J., Mayrhofer R.M., Shah G.J., Graesser D.T., Rienstra C.M. Dipole tensor-based atomic-resolution structure determination of a nanocrystalline protein by solid-state NMR. Proc. Natl. Acad. Sci. USA 2008, 105:4621-4626.
35. Frederick K.K., Debelouchina G.T., Kayatekin C., Dorminy T., Jacavone A.C., Griffin R.G., Lindquist S. Distinct prion strains are defined by amyloid core structure and chaperone binding site dynamics. Chem. Biol. 2014, 21:295-305.
36. Frost B., Jacks R.L., Diamond M.I. Propagation of tau misfolding from the outside to the inside of a cell. J.Biol. Chem. 2009, 284:12845-12852.
37. Frost B., Ollesch J., Wille H., Diamond M.I. Conformational diversity of wild-type Tau fibrils specified by templated conformation change. J.Biol. Chem. 2009, 284:3546-3551.
38. Gath J., Bousset L., Habenstein B., Melki R., Böckmann A., Meier B.H. Unlike twins: an NMR comparison of two α-synuclein polymorphs featuring different toxicity. PLoS ONE 2014, 9:e90659.
39. Giannakopoulos P., Herrmann F.R., Bussière T., Bouras C., Kövari E., Perl D.P., Morrison J.H., Gold G., Hof P.R. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003, 60:1495-1500.
40. Giasson B.I., Forman M.S., Higuchi M., Golbe L.I., Graves C.L., Kotzbauer P.T., Trojanowski J.Q., Lee V.M.Y. Initiation and synergistic fibrillization of tau and α-synuclein. Science 2003, 300:636-640.
41. Goldsbury C., Frey P., Olivieri V., Aebi U., Müller S.A. Multiple assembly pathways underlie amyloid-β fibril polymorphisms. J.Mol. Biol. 2005, 352:282-298.
42. Gravina S.A., Ho L., Eckman C.B., Long K.E., Otvos L., Younkin L.H., Suzuki N., Younkin S.G. Amyloid β protein (A β) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A β 40 or A β 42(43). J.Biol. Chem. 1995, 270:7013-7016.
43. Guo J.L., Lee V.M.Y. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat. Med. 2014, 20:130-138.
44. Guo J.L., Covell D.J., Daniels J.P., Iba M., Stieber A., Zhang B., Riddle D.M., Kwong L.K., Xu Y., Trojanowski J.Q., Lee V.M.Y. Distinct α-synuclein strains differentially promote tau inclusions in neurons. Cell 2013, 154:103-117.
45. Hardy J., Revesz T. The spread of neurodegenerative disease. N.Engl. J. Med. 2012, 366:2126-2128.
46. Heise H., Hoyer W., Becker S., Andronesi O.C., Riedel D., Baldus M. Molecular-level secondary structure, polymorphism, and dynamics of full-length α-synuclein fibrils studied by solid-state NMR. Proc. Natl. Acad. Sci. USA 2005, 102:15871-15876.
47. Heise H., Celej M.S., Becker S., Riedel D., Pelah A., Kumar A., Jovin T.M., Baldus M. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant α-synuclein. J.Mol. Biol. 2008, 380:444-450.
48. Helmus J.J., Surewicz K., Nadaud P.S., Surewicz W.K., Jaroniec C.P. Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc. Natl. Acad. Sci. USA 2008, 105:6284-6289.
49. Helmus J.J., Surewicz K., Surewicz W.K., Jaroniec C.P. Conformational flexibility of Y145Stop human prion protein amyloid fibrils probed by solid-state nuclear magnetic resonance spectroscopy. J.Am. Chem. Soc. 2010, 132:2393-2403.
50. Helmus J.J., Surewicz K., Apostol M.I., Surewicz W.K., Jaroniec C.P. Intermolecular alignment in Y145Stop human prion protein amyloid fibrils probed by solid-state NMR spectroscopy. J.Am. Chem. Soc. 2011, 133:13934-13937.
51. Hoshi M., Sato M., Matsumoto S., Noguchi A., Yasutake K., Yoshida N., Sato K. Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β. Proc. Natl. Acad. Sci. USA 2003, 100:6370-6375.
52. Hoyer W., Grönwall C., Jonsson A., Ståhl S., Härd T. Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation. Proc. Natl. Acad. Sci. USA 2008, 105:5099-5104.
53. Hughes A.J., Daniel S.E., Blankson S., Lees A.J. A clinicopathologic study of 100 cases of Parkinson's disease. Arch. Neurol. 1993, 50:140-148.
54. Iba M., Guo J.L., McBride J.D., Zhang B., Trojanowski J.Q., Lee V.M.Y. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J.Neurosci. 2013, 33:1024-1037.
55. Jiménez J.L., Guijarro J.I., Orlova E., Zurdo J., Dobson C.M., Sunde M., Saibil H.R. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 1999, 18:815-821.
56. Jones E.M., Surewicz W.K. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 2005, 121:63-72.
57. Jucker M., Walker L.C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013, 501:45-51.
58. Karantzoulis S., Galvin J.E. Distinguishing Alzheimer's disease from other major forms of dementia. Expert Rev. Neurother. 2011, 11:1579-1591.
59. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486-489.
60. Kfoury N., Holmes B.B., Jiang H., Holtzman D.M., Diamond M.I. Trans-cellular propagation of Tau aggregation by fibrillar species. J.Biol. Chem. 2012, 287:19440-19451.
61. Kheterpal I., Chen M., Cook K.D., Wetzel R. Structural differences in Abeta amyloid protofibrils and fibrils mapped by hydrogen exchange-mass spectrometry with on-line proteolytic fragmentation. J.Mol. Biol. 2006, 361:785-795.
62. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergström M., Savitcheva I., Huang G.F., Estrada S., et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319.
63. Klunk W.E., Lopresti B.J., Ikonomovic M.D., Lefterov I.M., Koldamova R.P., Abrahamson E.E., Debnath M.L., Holt D.P., Huang G.F., Shao L., et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-β in Alzheimer's disease brain but not in transgenic mouse brain. J.Neurosci. 2005, 25:10598-10606.
64. Knowles T.P.J., Waudby C.A., Devlin G.L., Cohen S.I.A., Aguzzi A., Vendruscolo M., Terentjev E.M., Welland M.E., Dobson C.M. An analytical solution to the kinetics of breakable filament assembly. Science 2009, 326:1533-1537.
65. Kodali R., Williams A.D., Chemuru S., Wetzel R. Abeta(1-40) forms five distinct amyloid structures whose β-sheet contents and fibril stabilities are correlated. J.Mol. Biol. 2010, 401:503-517.
66. Kryndushkin D.S., Wickner R.B., Tycko R. The core of Ure2p prion fibrils is formed by the N-terminal segment in a parallel cross-β structure: evidence from solid-state NMR. J.Mol. Biol. 2011, 409:263-277.
67. Ladiwala A.R.A., Litt J., Kane R.S., Aucoin D.S., Smith S.O., Ranjan S., Davis J., Van Nostrand W.E., Tessier P.M. Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity. J.Biol. Chem. 2012, 287:24765-24773.
68. Ladner C.L., Chen M., Smith D.P., Platt G.W., Radford S.E., Langen R. Stacked sets of parallel, in-register β-strands of β2-microglobulin in amyloid fibrils revealed by site-directed spin labeling and chemical labeling. J.Biol. Chem. 2010, 285:17137-17147.
69. Laganowsky A., Liu C., Sawaya M.R., Whitelegge J.P., Park J., Zhao M., Pensalfini A., Soriaga A.B., Landau M., Teng P.K., et al. Atomic view of a toxic amyloid small oligomer. Science 2012, 335:1228-1231.
70. Lam B., Masellis M., Freedman M., Stuss D.T., Black S.E. Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome. Alzheimers Res. Ther. 2013, 5:1.
71. Langer F., Eisele Y.S., Fritschi S.K., Staufenbiel M., Walker L.C., Jucker M. Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition. J.Neurosci. 2011, 31:14488-14495.
72. Lansbury P.T., Costa P.R., Griffiths J.M., Simon E.J., Auger M., Halverson K.J., Kocisko D.A., Hendsch Z.S., Ashburn T.T., Spencer R.G.S., et al. Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat. Struct. Biol. 1995, 2:990-998.
73. Lasagna-Reeves C.A., Glabe C.G., Kayed R. Amyloid-β annular protofibrils evade fibrillar fate in Alzheimer disease brain. J.Biol. Chem. 2011, 286:22122-22130.
74. Lemkau L.R., Comellas G., Kloepper K.D., Woods W.S., George J.M., Rienstra C.M. Mutant protein A30P α-synuclein adopts wild-type fibril structure, despite slower fibrillation kinetics. J.Biol. Chem. 2012, 287:11526-11532.
75. Lemkau L.R., Comellas G., Lee S.W., Rikardsen L.K., Woods W.S., George J.M., Rienstra C.M. Site-specific perturbations of α-synuclein fibril structure by the Parkinson's disease associated mutations A53T and E46K. PLoS ONE 2013, 8:e49750.
76. Lesné S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., Ashe K.H. A specific amyloid-β protein assembly in the brain impairs memory. Nature 2006, 440:352-357.
77. Lesné S.E., Sherman M.A., Grant M., Kuskowski M., Schneider J.A., Bennett D.A., Ashe K.H. Brain amyloid-β oligomers in ageing and Alzheimer's disease. Brain 2013, 136:1383-1398.
78. Li S., Hong S., Shepardson N.E., Walsh D.M., Shankar G.M., Selkoe D. Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009, 62:788-801.
79. Lomakin A., Teplow D.B., Kirschner D.A., Benedek G.B. Kinetic theory of fibrillogenesis of amyloid β-protein. Proc. Natl. Acad. Sci. USA 1997, 94:7942-7947.
80. Lopez del Amo J.M., Fink U., Dasari M., Grelle G., Wanker E.E., Bieschke J., Reif B. Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers. J.Mol. Biol. 2012, 421:517-524.
81. Lu J.X., Qiang W., Yau W.M., Schwieters C.D., Meredith S.C., Tycko R. Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue. Cell 2013, 154:1257-1268.
82. Luca S., Yau W.M., Leapman R., Tycko R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry 2007, 46:13505-13522.
83. Lührs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., Döbeli H., Schubert D., Riek R. 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc. Natl. Acad. Sci. USA 2005, 102:17342-17347.
84. Luk K.C., Kehm V., Carroll J., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M.Y. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338:949-953.
85. Luk K.C., Kehm V.M., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M.Y. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J.Exp. Med. 2012, 209:975-986.
86. Margittai M., Langen R. Template-assisted filament growth by parallel stacking of tau. Proc. Natl. Acad. Sci. USA 2004, 101:10278-10283.
87. Margittai M., Langen R. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy. Q.Rev. Biophys. 2008, 41:265-297.
88. Meinhardt J., Sachse C., Hortschansky P., Grigorieff N., Fändrich M. Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J.Mol. Biol. 2009, 386:869-877.
89. Meyer-Luehmann M., Coomaraswamy J., Bolmont T., Kaeser S., Schaefer C., Kilger E., Neuenschwander A., Abramowski D., Frey P., Jaton A.L., et al. Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 2006, 313:1781-1784.
90. Morales R., Duran-Aniotz C., Castilla J., Estrada L.D., Soto C. De novo induction of amyloid-β deposition invivo. Mol. Psychiatry 2012, 17:1347-1353.
91. Nelson R., Sawaya M.R., Balbirnie M., Madsen A.O., Riekel C., Grothe R., Eisenberg D. Structure of the cross-β spine of amyloid-like fibrils. Nature 2005, 435:773-778.
92. Nicoll A.J., Panico S., Freir D.B., Wright D., Terry C., Risse E., Herron C.E., O'Malley T., Wadsworth J.D.F., Farrow M.A., et al. Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity. Nat. Commun. 2013, 4:2416.
93. Niu Z., Zhao W., Zhang Z., Xiao F., Tang X., Yang J. The molecular structure of Alzheimer β-amyloid fibrils formed in the presence of phospholipid vesicles. Angew. Chem. Int. Ed. Engl. 2014, 53:9294-9297.
94. Noguchi A., Matsumura S., Dezawa M., Tada M., Yanazawa M., Ito A., Akioka M., Kikuchi S., Sato M., Ideno S., et al. Isolation and characterization of patient-derived, toxic, high mass amyloid β-protein (Abeta) assembly from Alzheimer disease brains. J.Biol. Chem. 2009, 284:32895-32905.
95. O'Nuallain B., Williams A.D., Westermark P., Wetzel R. Seeding specificity in amyloid growth induced by heterologous fibrils. J.Biol. Chem. 2004, 279:17490-17499.
96. Olofsson A., Lindhagen-Persson M., Sauer-Eriksson A.E., Ohman A. Amide solvent protection analysis demonstrates that amyloid-β(1-40) and amyloid-β(1-42) form different fibrillar structures under identical conditions. Biochem. J. 2007, 404:63-70.
97. Paravastu A.K., Leapman R.D., Yau W.M., Tycko R. Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils. Proc. Natl. Acad. Sci. USA 2008, 105:18349-18354.
98. Paravastu A.K., Qahwash I., Leapman R.D., Meredith S.C., Tycko R. Seeded growth of β-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc. Natl. Acad. Sci. USA 2009, 106:7443-7448.
99. Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 2005, 307:262-265.
100. Petkova A.T., Yau W.M., Tycko R. Experimental constraints on quaternary structure in Alzheimer's β-amyloid fibrils. Biochemistry 2006, 45:498-512.
101. Pham C.L.L., Kwan A.H., Sunde M. Functional amyloid: widespread in nature, diverse in purpose. Essays Biochem. 2014, 56:207-219.
102. Prusiner S.B. Biology and genetics of prions causing neurodegeneration. Annu. Rev. Genet. 2013, 47:601-623.
103. Qiang W., Yau W.M., Tycko R. Structural evolution of Iowa mutant β-amyloid fibrils from polymorphic to homogeneous states under repeated seeded growth. J.Am. Chem. Soc. 2011, 133:4018-4029.
104. Qiang W., Yau W.M., Luo Y., Mattson M.P., Tycko R. Antiparallel β-sheet architecture in Iowa-mutant β-amyloid fibrils. Proc. Natl. Acad. Sci. USA 2012, 109:4443-4448.
105. Qiang W., Kelley K., Tycko R. Polymorph-specific kinetics and thermodynamics of β-amyloid fibril growth. J.Am. Chem. Soc. 2013, 135:6860-6871.
106. Resende R., Ferreiro E., Pereira C., Resende de Oliveira C. Neurotoxic effect of oligomeric and fibrillar species of amyloid-β peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 2008, 155:725-737.
107. Rosen R.F., Fritz J.J., Dooyema J., Cintron A.F., Hamaguchi T., Lah J.J., LeVine H., Jucker M., Walker L.C. Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats. J.Neurochem. 2012, 120:660-666.
108. Sc) molecules with different conformations. Nat. Med. 1998, 4:1157-1165.
109. Sandberg A., Luheshi L.M., Söllvander S., Pereira de Barros T., Macao B., Knowles T.P.J., Biverstål H., Lendel C., Ekholm-Petterson F., Dubnovitsky A., et al. Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering. Proc. Natl. Acad. Sci. USA 2010, 107:15595-15600.
110. Sanders D.W., Kaufman S.K., DeVos S.L., Sharma A.M., Mirbaha H., Li A., Barker S.J., Foley A.C., Thorpe J.R., Serpell L.C., et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 2014, 82:1271-1288.
111. Sarkar B., Mithu V.S., Chandra B., Mandal A., Chandrakesan M., Bhowmik D., Madhu P.K., Maiti S. Significant structural differences between transient amyloid-β oligomers and less-toxic fibrils in regions known to harbor familial Alzheimer's mutations. Angew. Chem. Int. Ed. Engl. 2014, 53:6888-6892.
112. Sato T., Kienlen-Campard P., Ahmed M., Liu W., Li H., Elliott J.I., Aimoto S., Constantinescu S.N., Octave J.N., Smith S.O. Inhibitors ofamyloid toxicity based on β-sheet packing of Abeta40 and Abeta42. Biochemistry 2006, 45:5503-5516.
113. Sawaya M.R., Sambashivan S., Nelson R., Ivanova M.I., Sievers S.A., Apostol M.I., Thompson M.J., Balbirnie M., Wiltzius J.J.W., McFarlane H.T., et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 2007, 447:453-457.
114. Scheidt H.A., Morgado I., Rothemund S., Huster D., Fändrich M. Solid-state NMR spectroscopic investigation of Aβ protofibrils: implication of a β-sheet remodeling upon maturation into terminal amyloid fibrils. Angew. Chem. Int. Ed. Engl. 2011, 50:2837-2840.
115. Scheidt H.A., Morgado I., Huster D. Solid-state NMR reveals a close structural relationship between amyloid-β protofibrils and oligomers. J.Biol. Chem. 2012, 287:22822-22826.
116. Schneider J.A., Watts R.L., Gearing M., Brewer R.P., Mirra S.S. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 1997, 48:959-969.
117. Schutz A.K., Vagt T., Huber M., Ovchinnikova O.Y., Cadalbert R., Wall J., Guntert P., Bockmann A., Glockshuber R., Meier B.H. Atomic-resolution three-dimensional structure of amyloid-β fibrils bearing the Osaka mutation. Angew. Chem. Int. Ed. 2014, 53:1-6.
118. Sengupta I., Nadaud P.S., Jaroniec C.P. Protein structure determination with paramagnetic solid-state NMR spectroscopy. Acc. Chem. Res. 2013, 46:2117-2126.
119. Serpell L.C., Smith J.M. Direct visualisation of the β-sheet structure of synthetic Alzheimer's amyloid. J.Mol. Biol. 2000, 299:225-231.
120. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008, 14:837-842.
121. Shen Y., Delaglio F., Cornilescu G., Bax A. TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J.Biomol. NMR 2009, 44:213-223.
122. Shewmaker F., Wickner R.B., Tycko R. Amyloid of the prion domain of Sup35p has an in-register parallel β-sheet structure. Proc. Natl. Acad. Sci. USA 2006, 103:19754-19759.
123. Spies P.E., Slats D., Sjögren J.M.C., Kremer B.P.H., Verhey F.R.J., Rikkert M.G., Verbeek M.M. The cerebrospinal fluid amyloid β42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia. Curr. Alzheimer Res. 2010, 7:470-476.
124. Stöhr J., Watts J.C., Mensinger Z.L., Oehler A., Grillo S.K., DeArmond S.J., Prusiner S.B., Giles K. Purified and synthetic Alzheimer's amyloid beta (Aβ) prions. Proc. Natl. Acad. Sci. USA 2012, 109:11025-11030.
125. Stöhr J., Condello C., Watts J.C., Bloch L., Oehler A., Nick M., DeArmond S.J., Giles K., DeGrado W.F., Prusiner S.B. Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice. Proc. Natl. Acad. Sci. USA 2014, 111:10329-10334.
126. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., Blake C.C.F. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J.Mol. Biol. 1997, 273:729-739.
127. Tay W.M., Huang D., Rosenberry T.L., Paravastu A.K. The Alzheimer's amyloid-β(1-42) peptide forms off-pathway oligomers and fibrils that are distinguished structurally by intermolecular organization. J.Mol. Biol. 2013, 425:2494-2508.
128. Taylor K.L., Cheng N., Williams R.W., Steven A.C., Wickner R.B. Prion domain initiation of amyloid formation invitro from native Ure2p. Science 1999, 283:1339-1343.
129. Telling G.C., Parchi P., DeArmond S.J., Cortelli P., Montagna P., Gabizon R., Mastrianni J., Lugaresi E., Gambetti P., Prusiner S.B. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996, 274:2079-2082.
130. Thal D.R., Rüb U., Orantes M., Braak H. Phases of A β-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58:1791-1800.
131. Tomic J.L., Pensalfini A., Head E., Glabe C.G. Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Neurobiol. Dis. 2009, 35:352-358.
132. Török M., Milton S., Kayed R., Wu P., McIntire T., Glabe C.G., Langen R. Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. J.Biol. Chem. 2002, 277:40810-40815.
133. Toyama B.H., Weissman J.S. Amyloid structure: conformational diversity and consequences. Annu. Rev. Biochem. 2011, 80:557-585.
134. Toyama B.H., Kelly M.J.S., Gross J.D., Weissman J.S. The structural basis of yeast prion strain variants. Nature 2007, 449:233-237.
135. Tycko R. Solid-state NMR studies of amyloid fibril structure. Annu. Rev. Phys. Chem. 2011, 62:279-299.
136. Tycko R. Physical and structural basis for polymorphism in amyloid fibrils. Protein Sci. 2014, 23:1528-1539.
137. Tycko R., Sciarretta K.L., Orgel J.P., Meredith S.C. Evidence for novel β-sheet structures in Iowa mutant β-amyloid fibrils. Biochemistry 2009, 48:6072-6084.
138. Tycko R., Savtchenko R., Ostapchenko V.G., Makarava N., Baskakov I.V. The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry 2010, 49:9488-9497.
139. Van Melckebeke H., Wasmer C., Lange A., Ab E., Loquet A., Böckmann A., Meier B.H. Atomic-resolution three-dimensional structure of HET-s(218-289) amyloid fibrils by solid-state NMR spectroscopy. J.Am. Chem. Soc. 2010, 132:13765-13775.
140. Volpicelli-Daley L.A., Luk K.C., Patel T.P., Tanik S.A., Riddle D.M., Stieber A., Meaney D.F., Trojanowski J.Q., Lee V.M.Y. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011, 72:57-71.
141. 311)) forming β structure. Proc. Natl. Acad. Sci. USA 2000, 97:5129-5134.
142. Walker L.C., Diamond M.I., Duff K.E., Hyman B.T. Mechanisms of protein seeding in neurodegenerative diseases. JAMA Neurol. 2013, 70:304-310.
143. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation invivo. Nature 2002, 416:535-539.
144. Watts J.C., Condello C., Stöhr J., Oehler A., Lee J., DeArmond S.J., Lannfelt L., Ingelsson M., Giles K., Prusiner S.B. Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients. Proc. Natl. Acad. Sci. USA 2014, 111:10323-10328.
145. Wetzel R. Kinetics and thermodynamics of amyloid fibril assembly. Acc. Chem. Res. 2006, 39:671-679.
146. Wickner R.B., Dyda F., Tycko R. Amyloid of Rnq1p, the basis of the [PIN+] prion, has a parallel in-register β-sheet structure. Proc. Natl. Acad. Sci. USA 2008, 105:2403-2408.
147. Wickner R.B., Shewmaker F., Edskes H., Kryndushkin D., Nemecek J., McGlinchey R., Bateman D., Winchester C.L. Prion amyloid structure explains templating: how proteins can be genes. FEMS Yeast Res. 2010, 10:980-991.
148. Williams A.D., Sega M., Chen M., Kheterpal I., Geva M., Berthelier V., Kaleta D.T., Cook K.D., Wetzel R. Structural properties of Abeta protofibrils stabilized by a small molecule. Proc. Natl. Acad. Sci. USA 2005, 102:7115-7120.
149. Wu J.W., Breydo L., Isas J.M., Lee J., Kuznetsov Y.G., Langen R., Glabe C. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid β but do not seed fibril formation. J.Biol. Chem. 2010, 285:6071-6079.
150. Xue W.F., Hellewell A.L., Gosal W.S., Homans S.W., Hewitt E.W., Radford S.E. Fibril fragmentation enhances amyloid cytotoxicity. J.Biol. Chem. 2009, 284:34272-34282.
151. Yu L., Edalji R., Harlan J.E., Holzman T.F., Lopez A.P., Labkovsky B., Hillen H., Barghorn S., Ebert U., Richardson P.L., et al. Structural characterization of a soluble amyloid β-peptide oligomer. Biochemistry 2009, 48:1870-1877.